News Archives - Inify Laboratories

Inify Laboratories announces CQC registration and full operational launch of its state-of-the-art UK histopathology laboratory

News 2026-05-27

South Oxfordshire, UK – May 27, 2026 – Inify Laboratories, a unique laboratory service that provides diagnostics within pathology, today announced that it has successfully achieved registration with the Care […]

Gastrointestinal Service Launch and Progress in the UK Expansion

News 2026-02-27

In the panel discussion for the fourth quarter of 2025, Inify’s CEO Fredrik Palm, Product Manager Kristian Eurén and the panel lead Ole Eikland discuss key highlights of the period. […]

Inify Laboratories establishes its UK laboratory at Milton Park

News 2025-10-02

Inify is establishing its UK laboratory within Nebula, a pioneering research and development workspace at Milton Park – one of the UK’s leading science and technology clusters, located just outside […]

Inify cuts diagnostic waiting times by weeks – now entering the UK market

News 2025-08-29

Inify Laboratories has achieved a measurable impact in prostate cancer diagnostics. Official statistics from the Swedish Cancer Registry show that the company has shortened waiting times for prostate biopsies by […]

Inify Laboratories enter a research partnership with the Department of Molecular Medicine and Surgery at Karolinska Institutet aiming to advance precision diagnostics within prostate cancer

Investor News, News 2024-11-05

STOCKHOLM – November 05, 2024 – Inify Laboratories, a unique laboratory service that provides cancer diagnostics within pathology, is proud to announce a partnership with the ProMort research team at […]

Inify Laboratories gets honorable mention by the Royal Swedish Academy of Engineering Sciences (IVA) at the Smart Industry business competition 2024

News 2024-10-10

“Inify receives an honorable mention in the Smart Industry business competition 2024 for their ultramodern laboratory that combines an industrial approach with innovations within healthcare processes. Their technology is based […]

Finansavisen highlights Inify Laboratories

News 2023-07-03

Norwegian financial newspaper Finansavisen highlights Inify Laboratories in a report from the laboratory in Solna. CEO Fredrik Palm and Chief Medical Officer Claes Lindh discuss challenges in healthcare, market potential and what makes Inify so unique.

Inify Laboratories announces CQC registration and full operational launch of its state-of-the-art UK histopathology laboratory

Gastrointestinal Service Launch and Progress in the UK Expansion

Inify Laboratories establishes its UK laboratory at Milton Park

Inify cuts diagnostic waiting times by weeks – now entering the UK market

Inify Laboratories enter a research partnership with the Department of Molecular Medicine and Surgery at Karolinska Institutet aiming to advance precision diagnostics within prostate cancer

Inify Laboratories gets honorable mention by the Royal Swedish Academy of Engineering Sciences (IVA) at the Smart Industry business competition 2024

Finansavisen highlights Inify Laboratories

Inify’s first ultramodern laboratory on track

Inify Laboratories – Extended subscription period

Inify Laboratories – extra bolagsstämma 2022-05-09

Our services

Inify Laboratories

For Investors

Contact us

Social media